TTR and carcinoma of esophagus: Although at present SAA, transthyretin and apolipoprotein A-1 as individual markers may be too non-specific to influence therapeutic decisions, taken together, these plasma proteins may represent a panel of circulating markers that provide information about response to therapy in oesophageal cancer.